E-GEOD-20371
Ontology highlight
ABSTRACT:
PROVIDER: E-GEOD-20371 | ExpressionAtlas | 2015-07-07
REPOSITORIES: ExpressionAtlas
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| E-GEOD-20371-analysis-methods.tsv | Tabular | |||
| E-GEOD-20371-atlasExperimentSummary.Rdata | Rdata | |||
| E-GEOD-20371-configuration.xml | Xml | |||
| E-GEOD-20371-percentile-ranks.tsv | Tabular | |||
| E-GEOD-20371.condensed-sdrf.tsv | Tabular |
Items per page: 5 1 - 5 of 82 |
Similar Datasets
Project description:Finding direct target genes of VND7
2015-06-18 | E-GEOD-24169 | ExpressionAtlas
Project description:Analysis of TBR1 downnstream target genes in embryonic forebrains
2015-07-21 | E-GEOD-49237 | ExpressionAtlas
Project description:Identification of target genes of translation-dependent signalling in Arabidopsis
2015-05-06 | E-GEOD-54573 | ExpressionAtlas
Project description:Beta-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/beta-catenin signaling
2025-01-24 | E-GEOD-44097 | ExpressionAtlas
Project description:The PPAR (Peroxisome proliferator-activated receptor) family of nuclear receptors has three members: PPARg, PPARa and PPARd. Although they share similar structures, their biological functions are distinct. PPARg controls lipid storage and adipogenesis, while PPARd is associated with fat burning. The highly specific synthetic ligand for PPARd, GW501516, is a promising drug candidate for obesity and diabetes. Here we use Affymetrix microarray to analyze gene expression profile in mouse embryo fibroblasts treated with 100 nM GW501516 for 0, 2, 8 and 24 hours. These data may provide new clues into the molecular mechanism by which GW501516 ameliorates obesity and diabetes. Wild type mouse embryonic fibroblasts (MEFs) stably infected with retroviruses MSCVpuro expressing PPARd were plated at 0.5 million per 10 cm dish. After overnight incubation, cells were treated with 100nM GW501516 for 0h, 2h, 8h and 48h. Cells were collected at subconfluent condition. Total RNAs were sequentially purified with Trizol (Invitrogen) and RNeasy kit (Qiagen) and analyzed in triplicate on Mouse Genome 430 2.0 Array (Affymetrix) at NIDDK Microarray Core Facility following standard protocols.
2013-12-31 | E-GEOD-20371 | biostudies-arrayexpress
Project description:Whole genome expression data comparison between WT and Cebpg-/- MEFs.
2015-07-17 | E-GEOD-47777 | ExpressionAtlas
Project description:In this study, we uncover the molecular mechanism that PPARD transactive-deficient pigs have large-eared feature. Evidently from this work, PPARD plays a vital role on inhibiting cartilage growth by regulating the transcription of critical genes for chondrogenesis in ligand dependent manner; the activation of sPPARD speeds up apoptosis in CSPCs, terminal differentiation of chondroblasts and matrix degradation in auricular cartilage. The transactive-deficient PPARD has not the capability to slow down cartilage growth and consequently causes that ear size of carried animals increases at a high growth rate. As the role of PPARD in cartilage is similar in pigs, mice and humans, and since cartilage development is well-conserved in animals, our data helps to better understanding of cartilage development and treatment of cartilage-related diseases.
2017-06-09 | GSE92370 | GEO
Project description:Cancer Res; 78(2); 399-409. ©2017 The nuclear receptor PPAR-β/δ (PPARD) has essential roles in fatty acid catabolism and energy homeostasis as well as cell differentiation, inflammation, and metabolism. However, its contributions to tumorigenesis are uncertain and have been disputed. Here, we provide evidence of tumor suppressive activity of PPARD in prostate cancer through a noncanonical and ligand-independent pathway. PPARD was downregulated in prostate cancer specimens. In murine prostate epithelium, PPARD gene deletion resulted in increased cellularity. Genetic modulation of PPARD in human prostate cancer cell lines validated the tumor suppressive activity of this gene in vitro and in vivo Mechanistically, PPARD exerted its activity in a DNA binding-dependent and ligand-independent manner. We identified a novel set of genes repressed by PPARD that failed to respond to ligand-mediated activation. Among these genes, we observed robust regulation of the secretory trefoil factor family (TFF) members, including a causal and correlative association of TFF1 with prostate cancer biology in vitro and in patient specimens. Overall, our results illuminate the oncosuppressive function of PPARD and understanding of the pathogenic molecular pathways elicited by this nuclear receptor.Significance: These findings challenge the presumption that the function of the nuclear receptor PPARβ/δ in cancer is dictated by ligand-mediated activation.
2018-01-29 | GSE95054 | GEO
Project description:Transcriptional profiling of Drosophila neoplastic tumors to identify Ets21C dependent target genes
2016-04-07 | E-MTAB-4315 | ExpressionAtlas